Spatiotemporal pharmacometabolomics based on ambient mass spectrometry imaging to evaluate the metabolism and hepatotoxicity of amiodarone in HepG2 spheroids

Three-dimensional (3D) cell spheroid models combined with mass spectrometry imaging (MSI) enables innovative investigation of in vivo-like biological processes under different physiological and pathological conditions. Herein, airflow-assisted desorption electrospray ionization-MSI (AFADESI-MSI) was...

Full description

Bibliographic Details
Main Authors: Limei Li, Qingce Zang, Xinzhu Li, Ying Zhu, Shanjing Wen, Jiuming He, Ruiping Zhang, Zeper Abliz
Format: Article
Language:English
Published: Elsevier 2023-05-01
Series:Journal of Pharmaceutical Analysis
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2095177923000679
_version_ 1797812071050510336
author Limei Li
Qingce Zang
Xinzhu Li
Ying Zhu
Shanjing Wen
Jiuming He
Ruiping Zhang
Zeper Abliz
author_facet Limei Li
Qingce Zang
Xinzhu Li
Ying Zhu
Shanjing Wen
Jiuming He
Ruiping Zhang
Zeper Abliz
author_sort Limei Li
collection DOAJ
description Three-dimensional (3D) cell spheroid models combined with mass spectrometry imaging (MSI) enables innovative investigation of in vivo-like biological processes under different physiological and pathological conditions. Herein, airflow-assisted desorption electrospray ionization-MSI (AFADESI-MSI) was coupled with 3D HepG2 spheroids to assess the metabolism and hepatotoxicity of amiodarone (AMI). High-coverage imaging of >1100 endogenous metabolites in hepatocyte spheroids was achieved using AFADESI-MSI. Following AMI treatment at different times, 15 metabolites of AMI involved in N-desethylation, hydroxylation, deiodination, and desaturation metabolic reactions were identified, and according to their spatiotemporal dynamics features, the metabolic pathways of AMI were proposed. Subsequently, the temporal and spatial changes in metabolic disturbance within spheroids caused by drug exposure were obtained via metabolomic analysis. The main dysregulated metabolic pathways included arachidonic acid and glycerophospholipid metabolism, providing considerable evidence for the mechanism of AMI hepatotoxicity. In addition, a biomarker group of eight fatty acids was selected that provided improved indication of cell viability and could characterize the hepatotoxicity of AMI. The combination of AFADESI-MSI and HepG2 spheroids can simultaneously obtain spatiotemporal information for drugs, drug metabolites, and endogenous metabolites after AMI treatment, providing an effective tool for in vitro drug hepatotoxicity evaluation.
first_indexed 2024-03-13T07:32:08Z
format Article
id doaj.art-09d5850106504762a8d26554380abb47
institution Directory Open Access Journal
issn 2095-1779
language English
last_indexed 2024-03-13T07:32:08Z
publishDate 2023-05-01
publisher Elsevier
record_format Article
series Journal of Pharmaceutical Analysis
spelling doaj.art-09d5850106504762a8d26554380abb472023-06-04T04:23:39ZengElsevierJournal of Pharmaceutical Analysis2095-17792023-05-01135483493Spatiotemporal pharmacometabolomics based on ambient mass spectrometry imaging to evaluate the metabolism and hepatotoxicity of amiodarone in HepG2 spheroidsLimei Li0Qingce Zang1Xinzhu Li2Ying Zhu3Shanjing Wen4Jiuming He5Ruiping Zhang6Zeper Abliz7State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100050, ChinaState Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100050, ChinaState Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100050, ChinaState Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100050, ChinaState Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100050, ChinaState Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100050, ChinaState Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100050, China; Corresponding author.State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100050, China; Key Laboratory of Mass Spectrometry Imaging and Metabolomics (Minzu University of China), National Ethnic Affairs Commission, Beijing, 100081, China; Center for Imaging and Systems Biology, College of Life and Environmental Sciences, Minzu University of China, Beijing, 100081, China; Corresponding author. State Key Laboratory of Bioactive Substance and Function of Natural Medicines, Institute of Materia Medica, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing, 100050, China.Three-dimensional (3D) cell spheroid models combined with mass spectrometry imaging (MSI) enables innovative investigation of in vivo-like biological processes under different physiological and pathological conditions. Herein, airflow-assisted desorption electrospray ionization-MSI (AFADESI-MSI) was coupled with 3D HepG2 spheroids to assess the metabolism and hepatotoxicity of amiodarone (AMI). High-coverage imaging of >1100 endogenous metabolites in hepatocyte spheroids was achieved using AFADESI-MSI. Following AMI treatment at different times, 15 metabolites of AMI involved in N-desethylation, hydroxylation, deiodination, and desaturation metabolic reactions were identified, and according to their spatiotemporal dynamics features, the metabolic pathways of AMI were proposed. Subsequently, the temporal and spatial changes in metabolic disturbance within spheroids caused by drug exposure were obtained via metabolomic analysis. The main dysregulated metabolic pathways included arachidonic acid and glycerophospholipid metabolism, providing considerable evidence for the mechanism of AMI hepatotoxicity. In addition, a biomarker group of eight fatty acids was selected that provided improved indication of cell viability and could characterize the hepatotoxicity of AMI. The combination of AFADESI-MSI and HepG2 spheroids can simultaneously obtain spatiotemporal information for drugs, drug metabolites, and endogenous metabolites after AMI treatment, providing an effective tool for in vitro drug hepatotoxicity evaluation.http://www.sciencedirect.com/science/article/pii/S2095177923000679Mass spectrometry imagingHepG2 spheroidsHepatotoxicityDrug metabolismAmiodarone
spellingShingle Limei Li
Qingce Zang
Xinzhu Li
Ying Zhu
Shanjing Wen
Jiuming He
Ruiping Zhang
Zeper Abliz
Spatiotemporal pharmacometabolomics based on ambient mass spectrometry imaging to evaluate the metabolism and hepatotoxicity of amiodarone in HepG2 spheroids
Journal of Pharmaceutical Analysis
Mass spectrometry imaging
HepG2 spheroids
Hepatotoxicity
Drug metabolism
Amiodarone
title Spatiotemporal pharmacometabolomics based on ambient mass spectrometry imaging to evaluate the metabolism and hepatotoxicity of amiodarone in HepG2 spheroids
title_full Spatiotemporal pharmacometabolomics based on ambient mass spectrometry imaging to evaluate the metabolism and hepatotoxicity of amiodarone in HepG2 spheroids
title_fullStr Spatiotemporal pharmacometabolomics based on ambient mass spectrometry imaging to evaluate the metabolism and hepatotoxicity of amiodarone in HepG2 spheroids
title_full_unstemmed Spatiotemporal pharmacometabolomics based on ambient mass spectrometry imaging to evaluate the metabolism and hepatotoxicity of amiodarone in HepG2 spheroids
title_short Spatiotemporal pharmacometabolomics based on ambient mass spectrometry imaging to evaluate the metabolism and hepatotoxicity of amiodarone in HepG2 spheroids
title_sort spatiotemporal pharmacometabolomics based on ambient mass spectrometry imaging to evaluate the metabolism and hepatotoxicity of amiodarone in hepg2 spheroids
topic Mass spectrometry imaging
HepG2 spheroids
Hepatotoxicity
Drug metabolism
Amiodarone
url http://www.sciencedirect.com/science/article/pii/S2095177923000679
work_keys_str_mv AT limeili spatiotemporalpharmacometabolomicsbasedonambientmassspectrometryimagingtoevaluatethemetabolismandhepatotoxicityofamiodaroneinhepg2spheroids
AT qingcezang spatiotemporalpharmacometabolomicsbasedonambientmassspectrometryimagingtoevaluatethemetabolismandhepatotoxicityofamiodaroneinhepg2spheroids
AT xinzhuli spatiotemporalpharmacometabolomicsbasedonambientmassspectrometryimagingtoevaluatethemetabolismandhepatotoxicityofamiodaroneinhepg2spheroids
AT yingzhu spatiotemporalpharmacometabolomicsbasedonambientmassspectrometryimagingtoevaluatethemetabolismandhepatotoxicityofamiodaroneinhepg2spheroids
AT shanjingwen spatiotemporalpharmacometabolomicsbasedonambientmassspectrometryimagingtoevaluatethemetabolismandhepatotoxicityofamiodaroneinhepg2spheroids
AT jiuminghe spatiotemporalpharmacometabolomicsbasedonambientmassspectrometryimagingtoevaluatethemetabolismandhepatotoxicityofamiodaroneinhepg2spheroids
AT ruipingzhang spatiotemporalpharmacometabolomicsbasedonambientmassspectrometryimagingtoevaluatethemetabolismandhepatotoxicityofamiodaroneinhepg2spheroids
AT zeperabliz spatiotemporalpharmacometabolomicsbasedonambientmassspectrometryimagingtoevaluatethemetabolismandhepatotoxicityofamiodaroneinhepg2spheroids